Invention Grant
- Patent Title: Triazine derivatives
- Patent Title (中): 三嗪衍生物
-
Application No.: US14549871Application Date: 2014-11-21
-
Publication No.: US09145427B2Publication Date: 2015-09-29
- Inventor: Thomas Allen Chappie , Christopher John Helal , Bethany Lyn Kormos , Jamison Byrce Tuttle , Patrick Robert Verhoest
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent J. Michael Dixon
- Main IPC: C07D487/04
- IPC: C07D487/04 ; C07D471/04 ; C07D498/04 ; C07D513/04 ; A61K31/53 ; A61K31/4353 ; A61P9/12 ; C07D519/00
Abstract:
The present invention is directed to a new class of triazine derivatives as described by formula I below in which A, X, R1, R2, R3, and R4 are as defined herein and to the use of the compounds as PDE10 inhibitors.
Public/Granted literature
- US20150080401A1 Triazine Derivatives Public/Granted day:2015-03-19
Information query
